GN Store Nord GN.CO
GN Store Nord is a Danish medical technology and audio company that designs and sells hearing aids (GN Hearing) and audio solutions for businesses and consumers (GN Audio), with a business model based on innovation and sales through specialized channels. GN Store Nord is at an inflection point: the sale of GN Hearing for $2.6 billion to Amplifon transforms its profile, allowing it to reduce debt of 7.48x EBITDA and focus on GN Audio. However, current fundamentals are weak (ROE 2.15%, operating margin 2.67%) and valuation is demanding (P/E 93.19), although the forward P/E of 21.78 suggests expectations of improvement.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
GN Store Nord is a Danish medical technology and audio company that designs and sells hearing aids (GN Hearing) and audio solutions for businesses and consumers (GN Audio), with a business model based on innovation and sales through specialized channels. GN Store Nord is at an inflection point: the sale of GN Hearing for $2.6 billion to Amplifon transforms its profile, allowing it to reduce debt of 7.48x EBITDA and focus on GN Audio. However, current fundamentals are weak (ROE 2.15%, operating margin 2.67%) and valuation is demanding (P/E 93.19), although the forward P/E of 21.78 suggests expectations of improvement.
Score by category
| Category | Score |
|---|---|
| Financial health | 3.4 |
| Quality / Moat | 2.8 |
| Valuation | 2.8 |
| Growth | 2.8 |
| Dividend | 1.5 |
| Momentum | 3.1 |
| Risk & Context | 4.0 |
OVERALL SCORE: 3.0/10
Context and risks
The sale of GN Hearing reduces exposure to the hearing aid business, but the company maintains high debt (ND/EBITDA 7.48) that must be refinanced in a rising rate environment in Europe (ECB hiking), making debt service more expensive.
News considered in the analysis
- Amplifon to acquire GN Hearing in $2.6bn deal — Venta de la unidad de audífonos por 2.600 millones de dólares: transforma el perfil de riesgo y aporta caja para reducir el elevado apalancamiento.
- GN Store Nord AS (GGNDF) (Q2 2026) Earnings Call Highlights: Margin Guidance Upgraded Amid ... — Mejora de la guía de márgenes, señal positiva de gestión operativa en un contexto de venta de la unidad principal.
- Is GN Store Nord (CPSE:GN) Now Fairly Priced After Volatile Recent Share Performance — Análisis de valoración sin información nueva relevante.
- Amplifon’s Big Bet Has Investors Hearing Alarm Bells — Noticia sobre el comprador, no sobre GN Store Nord; sin impacto directo en su valoración.
- Amplifon to Buy GN Store Nord Hearing-Aid Unit in $2.6 Billion Deal — Confirmación del acuerdo de venta, redundante con la primera noticia pero refuerza la materialidad del evento.
Verdict: Hold pending the closing of the sale and confirmation of debt reduction; execution risk remains high.
Main risk: High leverage (Net Debt/EBITDA 7.48) and dependence on the GN Hearing sale to deleverage; if the deal is delayed or terms worsen, financial health will remain severely compromised.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →